These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 4331238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early onset myasthenia gravis with atypical features.
    Agarwal P, Chapagain U, Deewan KR, Rana PV.
    Kathmandu Univ Med J (KUMJ); 2008; 6(2):231-4. PubMed ID: 18769095
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ocular signs and local treatment in myasthenia gravis.
    Hutsebaut B, Dralands L.
    Bull Soc Belge Ophtalmol; 1976; (173):692-703. PubMed ID: 1032881
    [No Abstract] [Full Text] [Related]

  • 6. The use of ACTH and corticosteroids in myasthenia gravis.
    Genkins G, Kornfeld P, Osserman KE, Namba T, Grob D, Brunner NG.
    Ann N Y Acad Sci; 1971 Sep 15; 183():369-74. PubMed ID: 4330763
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacology of myasthenia gravis.
    Dipalma JR.
    Am Fam Physician; 1980 Oct 15; 22(4):158-9. PubMed ID: 7424763
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of myasthenia--I.
    Br Med J; 1971 Apr 17; 2(5754):160-2. PubMed ID: 4325739
    [No Abstract] [Full Text] [Related]

  • 9. Pseudo plus-minus lid syndrome.
    Bandini F.
    Arch Neurol; 2009 May 17; 66(5):668-9. PubMed ID: 19433671
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Corticotropin therapy in myasthenia gravis: indications and limitations.
    Namba T, Shapiro MS, Brunner NG, Grob D.
    Neurology; 1970 Apr 17; 20(4):385. PubMed ID: 4327339
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Myasthenia gravis].
    Satoyoshi E, Nakazato H.
    Naika; 1971 Jun 17; 27(6):1440-4. PubMed ID: 4326414
    [No Abstract] [Full Text] [Related]

  • 15. [Drug therapy in myasthenia gravis].
    Aarli JA.
    Tidsskr Nor Laegeforen; 1971 Apr 10; 91(10):726-8. PubMed ID: 4325239
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
    Nigrovic V, Amann A, Bhatt S.
    Muscle Nerve; 2005 Dec 10; 32(6):745-50. PubMed ID: 16094654
    [Abstract] [Full Text] [Related]

  • 19. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC, Johns RJ.
    Johns Hopkins Med J; 1969 Jan 10; 124(1):1-8. PubMed ID: 5762895
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.